Verona pharma to host investor update on commercialization preparation for ensifentrine on october 18, 2023

London and raleigh, n.c., oct. 06, 2023 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma” or the “company”), announces it will hold an investor update in new york city for investors and analysts on wednesday, october 18, 2023, from 8:00 - 10:00 am et.

VRNA Ratings Summary

VRNA Quant Ranking